Patient delay prior to care-seeking in acute myocardial infarction during the outbreak of the coronavirus SARS-CoV2 pandemic

Eur J Cardiovasc Nurs. 2021 Nov 28;20(8):752-759. doi: 10.1093/eurjcn/zvab087.

Abstract

Aims: To examine patient delay in seeking medical care when afflicted by an acute myocardial infarction during March-June 2020.

Methods and results: This was a cross-sectional study in a region in Sweden during the first wave of the COVID-19 pandemic examining patients selected from the national registry (SWEDEHEART). Eligible patients were those with acute myocardial infarction, and a total of 602 patients were invited. A self-administered psychometric evaluated questionnaire, 'Patients' appraisal, emotions, and action tendencies preceding care-seeking in acute myocardial infarction' (AMI), was sent to the patients, and questions regarding COVID-19 were added. A total of 326 patients answered the questionnaire. Of these, 19% hesitated to seek medical care because of the pandemic, which was related to a fear that the healthcare services were already overcrowded with patients with COVID-19, followed by a fear of becoming infected with COVID-19 in hospital. Characteristics of this cohort were significantly higher prevalences of women, immigrants, smokers, and patients with type 2 diabetes.

Conclusions: During the outbreak and first wave of the COVID-19 pandemic, women and immigrants delayed seeking medical care for AMI because of fears about overcrowded hospitals and about becoming infected themselves. Therefore, during the COVID-19 pandemic, it is especially important to convey information about how and when to seek medical care. A collaboration involving the healthcare professionals, patient organizations, and the media would be desirable.

Keywords: Acute myocardial infarction; COVID-19; Patient delay; Symptoms.

MeSH terms

  • COVID-19*
  • Cross-Sectional Studies
  • Diabetes Mellitus, Type 2*
  • Disease Outbreaks
  • Female
  • Humans
  • Myocardial Infarction* / epidemiology
  • Myocardial Infarction* / therapy
  • Pandemics
  • RNA, Viral
  • SARS-CoV-2

Substances

  • RNA, Viral